pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 766 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
ACE-2016
Solid Tumor
Acepodia Inc
0 catalysts
Phase 1
ACE-232
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Acerand Therapeutics
0 catalysts
Phase 1
ACLX-001
Refractory Multiple Myeloma
$ACLXArcellx, Inc.
0 catalysts
Phase 1
← prev
page 2 of 26
next →
131
Pain89
Neurology1
ACR-2316
Endometrial Cancer
$ACRVAcrivon Therapeutics, Inc.
0 catalysts
Phase 1
ACT-101
Myasthenia Gravis
Alpha Cancer Technologies Inc
0 catalysts
Phase 1
ADCT-701
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Chiome Bioscience Inc
0 catalysts
Phase 1
ADRX-0405
Gastric Cancer
Adcentrx Therapeutics Inc
0 catalysts
Phase 1
ADRX-0706
Cervical Cancer
Adcentrx Therapeutics Inc
0 catalysts
Phase 1
ADU-1805
Solid Tumor
Sairopa BV
0 catalysts
Phase 1
AFA-281
Inflammatory Pain
AfaSci Inc
0 catalysts
Phase 1
AG-236
Polycythemia Vera
$AGIOAGIOS PHARMACEUTICALS, INC.
0 catalysts
Phase 1
AGEN-1571
Solid Tumor
$AGENAGENUS INC
0 catalysts
Phase 1
AGEN-1777
Colon Cancer
$AGENAGENUS INC
0 catalysts
Phase 1
AGEN-2373
Adrenal Gland Cancer
$AGENAGENUS INC
0 catalysts
Phase 1
AGT103-T
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Addimmune
0 catalysts
Phase 1
AGX-101
Bile Duct Cancer (Cholangiocarcinoma)
Angiex Inc
0 catalysts
Phase 1
AH-001
Androgenic Alopecia
Anhorn Medicines Co Ltd
0 catalysts
Phase 1
AH-101
Congestive Heart Failure (Heart Failure)
Acahealth Pharma and Biotech Co Ltd
0 catalysts
Phase 1
AIC-100
Anaplastic Thyroid Cancer
AffyImmune Therapeutics Inc
0 catalysts
Phase 1
AJ-111095
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Ajax Therapeutics Inc
0 catalysts
Phase 1
AJ-302
Chemotherapy Induced Peripheral Neuropathy
Annji Pharmaceutical Co Ltd
0 catalysts
Phase 1
AJA-001
Autism Spectrum Disorder (ASD)
Defloria LLC
0 catalysts
Phase 1
AKY-1189
Cervical Cancer
$AKTSAktis Oncology, Inc.
0 catalysts
Phase 1
ALA-002
Social Anxiety Disorder (SAD/Social Phobia)
PharmAla Biotech Inc
0 catalysts
Phase 1
ALLO-316
Metastatic Renal Cell Carcinoma
$ALLOAllogene Therapeutics, Inc.
0 catalysts
Phase 1
ALLO-329
Lupus Nephritis
$ALLOAllogene Therapeutics, Inc.
0 catalysts
Phase 1
ALM-412
Dystrophic Epidermolysis Bullosa
Almirall SA
0 catalysts
Phase 1
ALX-001
Alzheimer's Disease
Allyx Therapeutics Inc
0 catalysts
Phase 1
ALX-1
Bronchiectasis
Parathyroid hormone/parathyroid hormone-related peptide receptor
Vast Therapeutics Inc
0 catalysts
Phase 1
ALX-2004
Colorectal Cancer
$ALXOALX ONCOLOGY HOLDINGS INC
0 catalysts